SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1994 |
Sector | Life Science |
Employees | 1,310 |
Revenue | 1.8B USD (2023) |
Exelixis is a biopharmaceutical company focused on developing and commercializing small molecule therapies with the potential to improve the treatment of cancer. Exelixis was founded in 1994 and is based in Alameda, California.
DEAL STATS | # |
---|---|
Overall | 1 of 3 |
Sector (Life Science) | 1 of 3 |
Type (Add-on Acquisition) | 1 of 2 |
State (Oregon) | 1 of 1 |
Country (United States) | 1 of 2 |
Year (2000) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2005-01-14 |
X-Ceptor Therapeutics
San Diego, California, United States X-Ceptor Therapeutics, Inc. discovers and develops novel small molecule therapeutics that modulate nuclear receptors. |
Buy | - |